Give Your Grad the Gift of a Lifetime

Study Finds Nanomedicine Targeting Lymph Nodes Key to Triple Negative Breast Cancer Treatment

May 9, 2022

 • 

Read time:

5-15 mins
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Screen Shot 2022 05 06 At 4.32.40 PM
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Presented by Health Lab

Researchers at the U-M Rogel Cancer Center may have found a new way to treat an aggressive form of breast cancer. Duxin Sun, Ph.D., and professor at the College of Pharmacy led the study, finding that targeting the immune microenvironment in lymph nodes and tumors simultaneously led to long-term tumor remission in mice. The faculty expert explains how he and his team identified the new approach, using nanoparticles to increase the efficacy and his hopes for a clinical trial.

 

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.